| Dr Rose J Julius, DO | |
|
1200 S Columbia Rd - Altru Health System, Grand Forks, ND 58201 | |
| (701) 780-5000 | |
| (701) 780-3472 |
| Full Name | Dr Rose J Julius |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 18 Years |
| Location | 1200 S Columbia Rd - Altru Health System, Grand Forks, North Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316101074 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Altru Hospital | Grand forks, ND | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northeast Human Service Center | 1658341441 | 9 |
| North Dakota State Hospital | 5698734374 | 14 |
News Archive
A 25-year follow-up study of a comprehensive early health and education intervention program begun in the early 1970s shows that inner-city children who participated not only did better educationally, but had better physical and mental health in adulthood.
IncentOne (http://www.incentone.com), the leading provider of incentive solutions to the healthcare industry, and Discern Consulting, a firm specializing in the development and implementation of provider pay-for-performance programs, have partnered to deliver "the science of health incentives".
New data being released today by the Association of Oncology Social Work (AOSW) demonstrate the extraordinary financial hardships that often complicate or compromise a patient's battle against cancer. Sixty-three percent of oncology social workers surveyed said that financial issues reduce patients' compliance with their cancer treatment – even though that treatment is key to their recovery. Forty percent of patients reported depleting their savings, while almost 30% reported dealing with bill collectors.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that results from a series of preclinical studies show that bafetinib may be useful in preventing bone loss in cancer patients who are at high risk for this event.
› Verified 3 days ago
| Entity Name | Lake Region Human Service Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669411930 PECOS PAC ID: 8426941436 Enrollment ID: O20040204000457 |
News Archive
A 25-year follow-up study of a comprehensive early health and education intervention program begun in the early 1970s shows that inner-city children who participated not only did better educationally, but had better physical and mental health in adulthood.
IncentOne (http://www.incentone.com), the leading provider of incentive solutions to the healthcare industry, and Discern Consulting, a firm specializing in the development and implementation of provider pay-for-performance programs, have partnered to deliver "the science of health incentives".
New data being released today by the Association of Oncology Social Work (AOSW) demonstrate the extraordinary financial hardships that often complicate or compromise a patient's battle against cancer. Sixty-three percent of oncology social workers surveyed said that financial issues reduce patients' compliance with their cancer treatment – even though that treatment is key to their recovery. Forty percent of patients reported depleting their savings, while almost 30% reported dealing with bill collectors.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that results from a series of preclinical studies show that bafetinib may be useful in preventing bone loss in cancer patients who are at high risk for this event.
› Verified 3 days ago
| Entity Name | West Central Human Service Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649226713 PECOS PAC ID: 6002801107 Enrollment ID: O20040419000160 |
News Archive
A 25-year follow-up study of a comprehensive early health and education intervention program begun in the early 1970s shows that inner-city children who participated not only did better educationally, but had better physical and mental health in adulthood.
IncentOne (http://www.incentone.com), the leading provider of incentive solutions to the healthcare industry, and Discern Consulting, a firm specializing in the development and implementation of provider pay-for-performance programs, have partnered to deliver "the science of health incentives".
New data being released today by the Association of Oncology Social Work (AOSW) demonstrate the extraordinary financial hardships that often complicate or compromise a patient's battle against cancer. Sixty-three percent of oncology social workers surveyed said that financial issues reduce patients' compliance with their cancer treatment – even though that treatment is key to their recovery. Forty percent of patients reported depleting their savings, while almost 30% reported dealing with bill collectors.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that results from a series of preclinical studies show that bafetinib may be useful in preventing bone loss in cancer patients who are at high risk for this event.
› Verified 3 days ago
| Entity Name | Northeast Human Service Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366496341 PECOS PAC ID: 1658341441 Enrollment ID: O20040729000033 |
News Archive
A 25-year follow-up study of a comprehensive early health and education intervention program begun in the early 1970s shows that inner-city children who participated not only did better educationally, but had better physical and mental health in adulthood.
IncentOne (http://www.incentone.com), the leading provider of incentive solutions to the healthcare industry, and Discern Consulting, a firm specializing in the development and implementation of provider pay-for-performance programs, have partnered to deliver "the science of health incentives".
New data being released today by the Association of Oncology Social Work (AOSW) demonstrate the extraordinary financial hardships that often complicate or compromise a patient's battle against cancer. Sixty-three percent of oncology social workers surveyed said that financial issues reduce patients' compliance with their cancer treatment – even though that treatment is key to their recovery. Forty percent of patients reported depleting their savings, while almost 30% reported dealing with bill collectors.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that results from a series of preclinical studies show that bafetinib may be useful in preventing bone loss in cancer patients who are at high risk for this event.
› Verified 3 days ago
| Entity Name | Northwest Human Service Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770524613 PECOS PAC ID: 4183683196 Enrollment ID: O20041006000330 |
News Archive
A 25-year follow-up study of a comprehensive early health and education intervention program begun in the early 1970s shows that inner-city children who participated not only did better educationally, but had better physical and mental health in adulthood.
IncentOne (http://www.incentone.com), the leading provider of incentive solutions to the healthcare industry, and Discern Consulting, a firm specializing in the development and implementation of provider pay-for-performance programs, have partnered to deliver "the science of health incentives".
New data being released today by the Association of Oncology Social Work (AOSW) demonstrate the extraordinary financial hardships that often complicate or compromise a patient's battle against cancer. Sixty-three percent of oncology social workers surveyed said that financial issues reduce patients' compliance with their cancer treatment – even though that treatment is key to their recovery. Forty percent of patients reported depleting their savings, while almost 30% reported dealing with bill collectors.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that results from a series of preclinical studies show that bafetinib may be useful in preventing bone loss in cancer patients who are at high risk for this event.
› Verified 3 days ago
| Entity Name | Southeast Human Service Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932146941 PECOS PAC ID: 8527027556 Enrollment ID: O20041006000512 |
News Archive
A 25-year follow-up study of a comprehensive early health and education intervention program begun in the early 1970s shows that inner-city children who participated not only did better educationally, but had better physical and mental health in adulthood.
IncentOne (http://www.incentone.com), the leading provider of incentive solutions to the healthcare industry, and Discern Consulting, a firm specializing in the development and implementation of provider pay-for-performance programs, have partnered to deliver "the science of health incentives".
New data being released today by the Association of Oncology Social Work (AOSW) demonstrate the extraordinary financial hardships that often complicate or compromise a patient's battle against cancer. Sixty-three percent of oncology social workers surveyed said that financial issues reduce patients' compliance with their cancer treatment – even though that treatment is key to their recovery. Forty percent of patients reported depleting their savings, while almost 30% reported dealing with bill collectors.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that results from a series of preclinical studies show that bafetinib may be useful in preventing bone loss in cancer patients who are at high risk for this event.
› Verified 3 days ago
| Entity Name | North Dakota State Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649227075 PECOS PAC ID: 5698734374 Enrollment ID: O20041007000543 |
News Archive
A 25-year follow-up study of a comprehensive early health and education intervention program begun in the early 1970s shows that inner-city children who participated not only did better educationally, but had better physical and mental health in adulthood.
IncentOne (http://www.incentone.com), the leading provider of incentive solutions to the healthcare industry, and Discern Consulting, a firm specializing in the development and implementation of provider pay-for-performance programs, have partnered to deliver "the science of health incentives".
New data being released today by the Association of Oncology Social Work (AOSW) demonstrate the extraordinary financial hardships that often complicate or compromise a patient's battle against cancer. Sixty-three percent of oncology social workers surveyed said that financial issues reduce patients' compliance with their cancer treatment – even though that treatment is key to their recovery. Forty percent of patients reported depleting their savings, while almost 30% reported dealing with bill collectors.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that results from a series of preclinical studies show that bafetinib may be useful in preventing bone loss in cancer patients who are at high risk for this event.
› Verified 3 days ago
| Entity Name | North Central Human Service Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477592533 PECOS PAC ID: 6305885013 Enrollment ID: O20050624000207 |
News Archive
A 25-year follow-up study of a comprehensive early health and education intervention program begun in the early 1970s shows that inner-city children who participated not only did better educationally, but had better physical and mental health in adulthood.
IncentOne (http://www.incentone.com), the leading provider of incentive solutions to the healthcare industry, and Discern Consulting, a firm specializing in the development and implementation of provider pay-for-performance programs, have partnered to deliver "the science of health incentives".
New data being released today by the Association of Oncology Social Work (AOSW) demonstrate the extraordinary financial hardships that often complicate or compromise a patient's battle against cancer. Sixty-three percent of oncology social workers surveyed said that financial issues reduce patients' compliance with their cancer treatment – even though that treatment is key to their recovery. Forty percent of patients reported depleting their savings, while almost 30% reported dealing with bill collectors.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that results from a series of preclinical studies show that bafetinib may be useful in preventing bone loss in cancer patients who are at high risk for this event.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rose J Julius, DO 2401 Demers Ave - Altru Business Center, Grand Forks, ND 58201 Ph: (701) 780-1891 | Dr Rose J Julius, DO 1200 S Columbia Rd - Altru Health System, Grand Forks, ND 58201 Ph: (701) 780-5000 |
News Archive
A 25-year follow-up study of a comprehensive early health and education intervention program begun in the early 1970s shows that inner-city children who participated not only did better educationally, but had better physical and mental health in adulthood.
IncentOne (http://www.incentone.com), the leading provider of incentive solutions to the healthcare industry, and Discern Consulting, a firm specializing in the development and implementation of provider pay-for-performance programs, have partnered to deliver "the science of health incentives".
New data being released today by the Association of Oncology Social Work (AOSW) demonstrate the extraordinary financial hardships that often complicate or compromise a patient's battle against cancer. Sixty-three percent of oncology social workers surveyed said that financial issues reduce patients' compliance with their cancer treatment – even though that treatment is key to their recovery. Forty percent of patients reported depleting their savings, while almost 30% reported dealing with bill collectors.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that results from a series of preclinical studies show that bafetinib may be useful in preventing bone loss in cancer patients who are at high risk for this event.
› Verified 3 days ago
Dr. Matthew Joseph Roller, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1300 S Columbia Rd, Grand Forks, ND 58201 Phone: 701-780-2300 | |
Ryan Ashley Greene, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4700 S Washington St Ste G, Grand Forks, ND 58201 Phone: 701-205-3000 Fax: 701-732-2501 | |
Dr. William Benjamin Pryatel Jr., M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1200 S. Columbia Rd, Grand Forks, ND 58201 Phone: 701-780-5000 Fax: 701-253-3999 | |
Kathryn M. Tevington, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 151 S 4th St, Suite 401, Grand Forks, ND 58201 Phone: 701-795-3000 Fax: 701-795-3050 | |
Dr. Kenneth Chidi Asogwa, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 860 S Columbia Rd, Grand Forks, ND 58201 Phone: 701-780-6697 Fax: 701-780-1507 | |
Jinal Desai, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: Altru Health System, 1200 South Columbia Road, Grand Forks, ND 58201 Phone: 701-780-5000 Fax: 701-780-4477 |